506260 — Anuh Pharma Income Statement
0.000.00%
Last trade - 00:00- IN₹12.81bn
- IN₹12.32bn
- IN₹5.27bn
- 84
- 21
- 97
- 81
Annual income statement for Anuh Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3,207 | 3,070 | 4,320 | 4,866 | 5,275 |
| Cost of Revenue | |||||
| Gross Profit | 777 | 768 | 1,022 | 1,090 | 1,260 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 2,882 | 2,839 | 4,024 | 4,501 | 4,836 |
| Operating Profit | 325 | 231 | 295 | 366 | 439 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 324 | 192 | 386 | 391 | 475 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 234 | 143 | 284 | 306 | 362 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 234 | 143 | 284 | 306 | 362 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 234 | 143 | 284 | 306 | 362 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 4.66 | 2.85 | 5.67 | 6.09 | 7.22 |
| Dividends per Share |